De Bernardin M, Bortolozzi E, Danieli F, Sicari U, Pinto G, Gatto F, Bragato N, Corso G F
U.L.S.S. N. 17-Regione Veneto, Presidio Ospedaliero di Noale, Servizio di Endoscopia.
Chir Ital. 1989 Feb;41(1):22-30.
Thorough long-term clinical, endoscopic and biopsy follow-up (from 6 months to greater than 8 years; mean follow-up: 3 years 3 months) of a group of 202 cases of apparently benign gastric ulcer has enabled us to evaluate the natural history of gastric ulcer in relation to medical therapy with H2-blockers and to patient compliance when using such drugs. The results confirm the efficacy of H2-antagonist therapy in gastric ulcer healing and in the prevention of relapse. Thorough follow-up, moreover, made it possible to keep surgical operations for non-neoplastic causes down to very low numbers, only 3 patients (1.5%) being operated on for haemorrhagic emergencies and 12 (6%) for non-response to therapy.
对一组202例看似良性胃溃疡患者进行了全面的长期临床、内镜及活检随访(随访时间从6个月至8年以上;平均随访时间:3年3个月),这使我们能够评估与使用H2阻滞剂进行药物治疗相关的胃溃疡自然病史以及患者使用此类药物时的依从性。结果证实了H2拮抗剂治疗在胃溃疡愈合及预防复发方面的疗效。此外,全面的随访使得因非肿瘤性原因进行的外科手术数量降至极低水平,仅有3例患者(1.5%)因出血急症接受手术,12例患者(6%)因治疗无反应接受手术。